The cytokines produced in response to increased ROS levels—e.g., IL-1β, IL-6, and TNF-α—activate the signaling through the NF-κB and signal transducer and activator of transcription 3 (STAT3) pathways, which have been demonstrated to participate in tumor progression [132,133,134]. This evidence concerns the gene STAT3 and neoplasm.